About NGC

What we do | Background | Mission Statement | Facilities | Distribution Network | Memberships | News Bulletins

What we do

Nigerian-German Chemicals PLC (NGC) is one of West Africa's leading manufacturers and distributors of speciality industrial chemicals and pharmaceuticals. Building on its solid multinational heritage, NGC's commitment to 'best practice' in business management and the pursuit of manufacturing excellence has enabled it to forge strategic relationships with a number of blue chip companies to complement its long standing collaboration with the Hoechst Group.

NGC stands out as Nigeria's foremost indigenous enterprise in the pharmaceutical and chemical fields, providing world-class companies with a vehicle to promote their products in this most challenging of environments.

Through its extensive nation-wide distribution network, NGC serves a number of key market sectors including:

• Healthcare
• Agrochemicals
• Veterinary / Animal Healthcare
• Oil & Gas Industry
• Household Consumer Products
• Industrial Chemicals

Background

NGC is a former subsidiary of Hoechst AG, Frankfurt, Germany. The company was incorporated in Nigeria in 1964. Since 1979, the Company has been listed on the Nigerian Stock Exchange as a Public quoted concern. 11,500 individuals and corporate institutions hold its shares. At the end of 1994, as part of its world-wide restructuring efforts, Hoechst AG divested its 40% stock in the company to a local investment company, Volker Securities & Investments Ltd. (Volker). Through further acquisition of shares on the Stock Exchange, Volker presently holds 46.6% of the paid-up share capital of NGC.

NGC's traditional activities have been in the manufacture and sales of pharmaceutical products, with its operations second in volume and profitability only to SmithKline Beecham. It also manufactures and sells speciality industrial chemical products consisting mainly of chemical intermediates for use in the production of paints, textiles, plastics, leather and soaps.

In the last four years, NGC's business has evolved beyond its traditional lines. It produces and markets household consumer products, markets Agrochemical and Veterinary products, and has additional collaborations in the pharmaceutical sector with other multinationals, including Parke-Davis / Warner Lambert and Solvay Pharma.

NGC has invested in four subsidiaries, namely a generics pharmaceutical company, an oil field production chemicals company, an insurance company, and a trading company in Ghana.

In three years, company sales have doubled, with strong indications of this being a sustainable trend in the medium term.

Mission Statement

"We want to build a major industrial corporation in Nigeria, which is profitable and well respected both locally and overseas. This will be achieved through expanding market share in our traditional pharmaceutical and industrial chemical sectors and by diversification into new business areas.

We aspire to being a good corporate citizen in Nigeria protecting the environment and caring for the interests of our customers, our staff and share holders. We are committed to providing high quality products and services and to marketing them innovatively and with integrity.

We want to develop a well trained and motivated workforce dedicated to the needs of our customers, professional in all areas of business and who enjoy contributing as a team to the success of Nigerian-German Chemicals PLC."

Facilities

NGC has two manufacturing sites.

Chemical Factory

The industrial chemical plant is the largest and most technically advanced in Nigeria. It combines facilities for the production of industrial chemical intermediates, oil and gas field chemicals, household consumer products and agro-chemicals.

It is divided into three main divisions:

• RESIN PLANT- installed capacity to produce 10,600 metric tons
• PIGMENT PREPARATION PLANT - installed capacity of 600 metric tons
• TEXTILE AUXILIARY PLANT - installed capacity to produce 3,800 metric tons

Each division works three shifts throughout the year.

more details »»

Pharmaceutical Factory

The pharmaceutical plant has an installed capacity to produce 1.5 billion tablets annually; an ongoing expansion will increase tableting capacity. Installation of a liquid processing plant took place in the first quarter of 1999. This plant meets the US Food and Drug Administrations GMP certification, and is one of the most modern plants in sub-Saharan Africa. It is subject to inspection by Aventis (Hoechst Marion Roussel) and forms the basis for local manufacturing licenses granted by the company's pharmaceutical partners.

The Pharmaceutical Division also undertakes toll manufacturing for suitable companies.

more details »»

Distribution Network

Through a nationwide distribution network, NGC goods can be found across the whole of Nigeria.

Map - click on thumbnail for full size (123KB)

Memberships

• member of the Pharmaceutical Manufactures Group (PMG)
• member of the Pharmaceutical Market Audit Group (PMAG)
• member of the Pharmaceutical Society of Nigeria (PSN)
• member of the Lagos Chamber of Commerce
• member of Nigerian-German Business Council
• quoted on the Nigerian Stock Exchange (NSE).

News Bulletins and Events

AGM (Annual General Meeting) - 24th July 2001

Last published accounts (2000) - 1st August 2001

AGM (Annual General Meeting) - 13th July 2000

Annual Management Workshop - 16-17th January 2000

Visit of Pharma Plant by French Ambassador

NGC Stock Price - for up-to-date price